about
Guidance for the practical management of the direct oral anticoagulants (DOACs) in VTE treatmentThe role of prothrombin complex concentrates in reversal of target specific anticoagulants.Management of anticoagulant-related intracranial hemorrhage: an evidence-based review.Preventive strategies against bleeding due to nonvitamin K antagonist oral anticoagulants.Emergency reversal of dabigatran for emergency surgery.In vitro reversal of supratherapeutic rivaroxaban levels with coagulation factor concentratesUse of Non-Vitamin K Antagonist Oral Anticoagulants in Special Patient Populations with Nonvalvular Atrial Fibrillation: A Review of the Literature and Application to Clinical Practice.New oral anticoagulants - a practical guide.Perioperative management of patients on new oral anticoagulants.Clinical impact and course of major bleeding with rivaroxaban and vitamin K antagonists.Rectus Sheath Hematoma Associated with Apixaban.Prothrombin complex concentrate for non-vitamin K oral anticoagulant reversal: good enough for now?
P2860
Q28076077-327965DA-6945-4AF4-A338-D5D85B4E622AQ33582537-74BF33E6-C631-409A-82C7-4B077088A60DQ33750215-18C2DD08-1D03-40DE-A8E7-53D0345C0475Q33854667-BDEB2E67-19AE-4B94-8642-3D9AFFB1A9C7Q35578443-2CB0A2AC-B53D-494B-94AC-BDE097242F93Q37242672-D5501745-8E02-467A-9B8A-8D9207EBFAB2Q38496232-4E84F35B-B8FF-4FCD-8070-368AC7F27394Q38580072-1261DAE2-E0EA-4579-BD90-CEC01CD09E02Q39201951-910FC989-C823-4B59-A898-5726DCF5DAB8Q40731819-B93867C0-E5B6-4043-8E93-E0B1DEA45343Q41224378-612C67D3-9285-41DB-8F42-36693DD7C558Q45866956-DCA6DAE6-D3A1-4E98-B068-A6EB73243865
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Reversal of target-specific oral anticoagulants.
@en
type
label
Reversal of target-specific oral anticoagulants.
@en
prefLabel
Reversal of target-specific oral anticoagulants.
@en
P2860
P1476
Reversal of target-specific oral anticoagulants.
@en
P2093
Mark Crowther
Scott Kaatz
P2860
P2888
P304
P356
10.1007/S11239-013-0923-Y
P577
2013-08-01T00:00:00Z